Minimal residual disease following autologous stem cell transplant in myeloma: impact on outcome is independent of induction regimen. (2016)
Attributed to:
Infrastructure for collaboration: Leeds MRC Medical Bioinformatics Centre
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3324/haematol.2015.128215
PubMed Identifier: 26471484
Publication URI: http://europepmc.org/abstract/MED/26471484
Type: Journal Article/Review
Volume: 101
Parent Publication: Haematologica
Issue: 2
ISSN: 0390-6078